Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
April 23, 2013
|
April 23, 2013
|
April 23, 2013
|
April 23, 2013
|
|
April 22, 2013
|
April 21, 2013
|
April 21, 2013
|
April 21, 2013
|